About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01452061

Evaluating the Validity of a Genetic Risk Assessment Tool in Identifying Autism Spectrum Disorder

There are three purposes to this study. The first purpose is to evaluate the value of a genetic test in determining risk for autism spectrum disorder. Processing for genetic samples will be completed ...

Lead sponsor: Thomas W. Frazier, Ph.D•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Thomas W. Frazier, Ph.D

Collaborators

IntegraGen SA

Age

1 - 12 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Diagnosis of Autistic Disorder, Pervasive Developmental Disorder, or Asperger's Disorder or have a clinical diagnosis of another developmental or psychiatric disorder (developmental/psychiatric controls), or have no specific developmental or psychiatric diagnosis (healthy controls).
•Age 1 to 12.

Exclusion Criteria

•For individuals with ASD and developmental concern controls, presence of a known or strongly suspected genetic disorder based on all available clinical data.
•Age less than 1 or greater than 12.
•Individuals for whom DNA is not available for analysis.
•Individuals for whom it is anticipated that they will not be available for follow-up at the Cleveland Clinic during the study period.
•Any medical diagnoses that might preclude participation in a low risk, non-interventional research study and any participant who at the discretion of the clinical investigator is not medically able to participate in the study (e.g., unable to comply with cheek swab or other procedure or has serious medical condition which precludes participation).

Related studies

DINO RCT - Treating Anxiety in Children With Autism

NCT06066983 · Autism Spectrum Disorder, Anxiety Disorders

Characterization of Social Cognition Profiles in Children and Adolescents With Neurodevelopmental Disorders: a Clinical Study Using a Multidimensional Battery

NCT07439276 · Neurodevelopmental Disorders, Autism Spectrum Disorder, and more

Developing Brain, Impulsivity and Compulsivity

NCT04631042 · Typical Development, Obsessive Compulsive Disorder, and more

A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Children With Developmental Delays

NCT07524192 · Autism Spectrum Disorder, Developmental Disabilities, and more

Comparing Two Different Emotion Therapies for Autistic Youth and Young Adults

NCT06158581 · Autism Spectrum Disorder

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 29, 2014Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment456

Start dateJan 2012

Last updatedJan 29, 2014

Condition

Autism Spectrum Disorder Attention Deficit/Hyperactivity Disorder Developmental Delay

Locations shown

Cleveland Clinic Center for Autism

Cleveland, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2014Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions